Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer

Carcinogenesis

Volumn 28, Issue 6, 2007, Pages 1247-1253

  Yang, Jun ^a,d   Ambrosone, Christine B ^a   Hong, Chi Chen ^a   Ahn, Jiyoung ^b   Rodriguez, Carmen ^c   Thun, Michael J ^c   Calle, E E Eugenia E ^c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d VIRGINIA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; MYELOPEROXIDASE; TOBACCO SMOKE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CIGARETTE SMOKING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RACE; RISK REDUCTION;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; PEROXIDASE; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RANDOM ALLOCATION; RISK FACTORS; SMOKING;

EID: 34447542861     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm016     Document Type: Article

References (86)

1. American Cancer Society (2006) Cancer Facts and Figures, 2005. Atlanta, GA, American Cancer Society.
2. MacMahon,B. (2006) Epidemiology and the causes of breast cancer. Int. J. Cancer, 118, 2373-2378.
3. Lancaster,J.R.,Jr et al. (2006) Tumors face NO problems? Cancer Res., 66, 6459-6462.
4. Arnhold,J. (2004) Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Mosc), 69, 4-9.
5. Forstermann,U. et al. (1994) Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension, 23, 1121-1131.
6. Moncada,S. et al. (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
7. Forstermann,U. et al. (2006) Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation, 113, 1708-1714.
8. Thomsen,L.L. et al. (1998) Role of nitric oxide in tumour progression: Lessons from human tumours. Cancer Metastasis Rev., 17, 107-118.
9. Wink,D.A. et al. (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis, 19, 711-721.
10. Drapier,J.C. et al. (1996) Modulation by nitric oxide of metalloprotein regulatory activities. Bioessays, 18, 549-556.
11. Murad,F. (2004) Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci. Rep., 24, 452-474.
12. Pance,A. (2006) Nitric oxide and hormones in breast cancer: Allies or enemies? Future Oncol., 2, 275-288.
13. Shen,Y.H. et al. (1998) Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett., 433, 125-131.
14. Polte,T. et al. (1997) Nitric oxide protects endothelial cells from tumor necrosis factor-alpha-mediated cytotoxicity: Possible involvement of cyclic GMP. FEBS Lett., 409, 46-48.
15. Wink,D.A. et al. (1996) The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: A direct correlation between nitric oxide formation and protection. Arch. Biochem. Biophys., 331, 241-248.
16. Wink,D.A. et al. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science, 254, 1001-1003.
17. Ambs,S. et al. (1997) Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J., 11, 443-448.
18. Lala,P.K. et al. (2001) Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol., 2, 149-156.
19. Calmels,S. et al. (1997) Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res., 57, 3365-3369.
20. Wei,X.M. et al. (2005) Effects of cigarette smoke on degranulation and NO production by mast cells and epithelial cells. Respir Res., 6, 108.
21. Barbera,J.A. et al. (2001) Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am J. Respir Crit. Care Med., 164, 709-713.
22. Su,Y. et al. (1998) Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J. Respir. Cell Mol. Biol., 19, 819-825.
23. Celermajer,D.S. et al. (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young dults. Circulation 88, 2149-2155.
24. Node,K. et al. (1997) Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am. J. Cardiol., 79, 1538-1541.
25. Reilly,M. et al. (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation, 94, 19-25.
26. Heitzer,T. et al. (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation, 93, 1346-1353.
27. Heitzer,T. et al. (1996) Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation, 94, 6-9.
28. Michaud,S.E. et al. (2006) Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: Role of NO and reactive oxygen species. J. Mol. Cell Cardiol., 41, 275-284.
29. Heitzer,T. et al. (2000) Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: Evidence for a dysfunctional nitric oxide synthase. Circ. Res., 86, E36-E41.
30. Lodovici,M. et al. (2000) Levels of 8-hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes. Free Radic. Biol. Med., 28, 13-17.
31. Nagler,R. et al. (2000) Effect of cigarette smoke on salivary proteins and enzyme activities. Arch. Biochem Biophys., 379, 229-236.
32. Pilz,H. et al. (2000) Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thromb. Res., 99, 209-221.
33. Chow,C.K. (1993) Cigarette smoking and oxidative damage in the lung. Ann. N Y Acad. Sci., 686, 289-298.
34. Beckman,J.S. et al. (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl Acad Sci. USA, 87, 1620-1624.
35. Sharma,R.N. et al. (1997) Reactive oxygen species formation in peripheral blood neutrophils in different types of smokers. Indian J. Med Res., 106, 475-480.
36. Forstermann,U. (2006) Endothelial NO synthase as a source of NO and superoxide. Eur. J. Clin. Pharmacol., 62, (suppl. 1), 5-12.
37. Tesauro,M. et al. (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl Acad Sci. USA, 97, 2832-2835.
38. Veldman,B.A. et al. (2002) The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J. Hypertens., 20, 2023-2027.
39. Gatti,G. et al. (2004) Possible role of nitric oxide in the biology of breast carcinoma: Review of the available literature. Breast, 13, 1-6.
40. Hoffmann,D. et al. (2001) The less harmful cigarette: A controversial issue. a tribute to Ernst L. Wynder Chem. Res. Toxicol. 14, 767-790.
41. Hecht,S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-1210.
42. Brown,N.S. et al. (2001) Hypoxia and oxidative stress in breast cancer. Oxidative stress: Its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res., 3, 323-327.
43. Kang,D.H. (2002) Oxidative stress, DNA damage, and breast cancer. AACN Clin. Issues, 13, 540-549.
44. Ozguner,F. et al. (2005) Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol. Ind. Health, 21 21-26.
45. Valko,M. et al. (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol. Interact., 160, 1-40.
46. Testa,A. et al. (2005) The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease. J. Hypertens., 23, 1825-1830.
47. Hsueh,Y.M. et al. (2005) Genetic polymorphisms of oxidative and antioxidant enzymes and arsenic-related hypertension. J. Toxicol. Environ. Health A, 68, 1471-1484.
48. Ghilardi,G. et al. (2003) Vascular invasion in human breast cancer is correlated to T->786C polymorphism of NOS3 gene. Nitric Oxide, 9, 118-122.
49. Lu,J. et al. (2006) Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer, 107, 2245-2253.
50. Royo,J.L. et al. (2006) Lack of association between NOS3 Glu298Asp and breast cancer risk: A case-control study. Breast Cancer Res. Treat., 100, 331-333.
51. Hefler,L.A. et al. (2006) Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res. Treat., 98, 151-155.
52. Klebanoff,S.J. (2005) Myeloperoxidase: Friend and foe. J. Leukoc. Biol., 77, 598-625.
53. Kiyohara,C. et al. (2005) NQ01, MPO, and the risk of lung cancer: a HuGE review. Genet. Med., 7, 463-478.
54. Hansson,M. et al. (2006) Biosynthesis, processing, and sorting of human myeloperoxidase. Arch. Biochem Biophys., 445, 214-224.
55. Feyler,A. et al. (2002) Point: Myeloperoxidase -463G -> a polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 11, 1550-1554.
56. Schabath,M.B. et al. (2002) A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer, 37 35-40.
57. Larsen,J.E. et al. (2006) CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis, 27, 525-532.
58. Olson,S.H. et al. (2004) Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol. Oncol., 93, 615-620.
59. Hung,R.J. et al. (2004) Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis, 25, 973-978.
60. Pakakasama,S. et al. (2003) Myeloperoxidase promotor polymorphism and risk of hepatoblastoma. Int. J. Cancer, 106, 205-207.
61. Ahn,J. et al. (2004) Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res., 64, 7634-7639.
62. Lin,S.C. et al. (2005) Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk. Eur. J. Cancer Prev., 14, 257-261.
63. Calle,E.E. et al. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: Rationale, study design, and baseline characteristics. Cancer, 94, 2490-2501.
64. Jenkins,D.C. et al. (1995) Roles of nitric oxide in tumor growth, Proc. Natl Acad. Sci. USA, 92, 4392-4396.
65. Cui,S. et al. (1994) Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res., 54, 2462-2467.
66. Hefler,L.A. et al. (2002) Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol. Oncol., 86, 134-137.
67. Conde,M.C. et al. (2006) Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol. Rep., 16, 353-359.
68. Medeiros,R. et al. (2002) Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur. J. Cancer Prev., 11, 343-350.
69. Riener,E.K. et al. (2004) Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol. Oncol., 93, 686-690.
70. Choi,J.Y. et al. (2006) Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer. Breast Cancer Res. Treat., 100, 213-218.
71. Medeiros,R.M. et al. (2002) Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clin. Cancer Res., 8, 3433-3437.
72. Schneider,B.P. et al. (2006) Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes. Breast Cancer Res. Treat., 96, 209-215.
73. Thebaud,B. et al. (1999) Inhaled and exhaled nitric oxide. Cell Mol. Life Sci., 55, 1103-1112.
74. Terry,P.D. et al. (2002) Cigarette smoking and the risk of breast cancer in women: A review of the literature. Cancer Epidemiol. Biomarkers Prev., 11, 953-971.
75. Michnovicz,J.J. et al. (1988) Increased urinary catechol estrogen excretion in female smokers. Steroids, 52, 69-83.
76. Michnovicz,J.J. et al. (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N. Engl. J. Med., 315, 1305-1309.
77. Tansavatdi,K. et al. (2004) The effects of smoking on estradiol metabolism. Minerva Ginecol., 56, 105-114.
78. Tanko,L.B. et al. (2004) An update on the antiestrogenic effect of smoking: A literature review with implications for researchers and practitioners. Menopause, 11, 104-109.
79. Mueck,A.O. et al. (2005) Smoking, estradiol metabolism and hormone replacement therapy. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 3, 45-54.
80. Zhang,W.Z. et al. (2006) Adverse effects of cigarette smoke on NO bioavailability: Role of arginine metabolism and oxidative stress. Hypertension, 48, 278-285.
81. Haynes,M.P. et al. (2003) Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J. Biol. Chem., 278, 2118-2123.
82. Kim,K.H. et al. (2005) Rapid, estrogen receptor-mediated signaling: Why is the endothelium so special. Sci. STKE, pe28.
83. Misra,R.R. et al. (2001) Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett., 164, 161-167.
84. Xu,L.L. et al. (2002) Counterpoint: The myeloperoxidase -463G-> a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol. Biomarkers Prev., 11, 1555-1559.
85. Brockstedt,U. et al. (2002) Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs). Mutat. Res., 516, 41-47.
86. Van Schooten,F.J. et al. (2004) Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol. Biomarkers Prev., 13, 828-833.